cysteine has been researched along with Cancer of Head in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, G; Fang, J; Feng, L; Guo, Y; Han, J; Jin, Y; Li, J; Li, R; Lian, M; Liu, H; Liu, S; Liu, Y; Ma, H; Ma, Z; Wan, H; Wang, R; Wang, Y; Yue, C; Zhai, J; Zhang, H | 1 |
| Chen, ZG; Majumdar, D; Rahman, MA; Shin, DM | 1 |
| Abnet, CC; Albanes, D; Diaw, L; Freedman, ND; Männistö, S; Miranti, EH; Murphy, G; Selhub, J; Stolzenberg-Solomon, RZ; Taylor, PR; Weinstein, SJ | 1 |
| Bhattacharya, A; Oven, SD; Rustum, YM; Seshadri, M; Tóth, K; Vaughan, MM | 1 |
| Bhattacharya, A; Cao, S; Chintala, S; Durrani, FA; Rustum, YM; Slocum, HK; Tóth, K | 1 |
| Cao, S; Chintala, S; Durrani, FA; Jensen, RL; Rustum, YM; Tóth, K; Vaughan, MM | 1 |
| Backer, JM; Chen, X; Guo, N; Kiesewetter, DO; Lang, L; Li, W; Ma, Y; Niu, G; Shen, B | 1 |
| Azrak, RG; Cao, S; Durrani, FA; Li, X; McLeod, HL; Pendyala, L; Rustum, YM; Shannon, WD; Smith, PF; Yu, J | 1 |
| Hamanaka, Y; Hashimoto, T; Hinoda, Y; Imate, Y; Okayama, N; Suehiro, Y; Uchida, K; Ueyama, Y; Yamashita, H | 1 |
| Azrak, RG; Bhattacharya, A; Cao, S; Durrani, FA; Frank, C; Hapke, G; Li, ZR; Rustum, YM; Tóth, K; Yin, MB | 1 |
| Cortes-Funes, H; Gamarra, S; Hitt, R; Manso, L; Medina, PP; Quintela-Fandino, M; Sanchez-Cespedes, M | 1 |
| Davidson, BJ; Pinto, JT; Qiao, C; Sacks, PG; Schantz, SP; Yellin, SA | 1 |
| Argentini, M; Barboule, N; Wasylyk, B | 1 |
| Estelin, R; Gerbaulet, A; Guichard, M; Haie, C; Lartigau, E; Lespinasse, F; Malaise, EP; Micheau, C; Prade, M; Richard, JM | 1 |
14 other study(ies) available for cysteine and Cancer of Head
| Article | Year |
|---|---|
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Amino Acid Transport System X-AG; Amino Acid Transport System y+; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Proliferation; Cysteine; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Squamous Cell Carcinoma of Head and Neck | 2017 |
Anticancer activity of drug conjugates in head and neck cancer cells.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cysteine; Esters; Head and Neck Neoplasms; Humans; Hydrogen-Ion Concentration; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Papillomavirus Infections; Sexually Transmitted Diseases | 2016 |
Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers.
Topics: Adenocarcinoma; Antioxidants; Biomarkers; Carcinoma, Squamous Cell; Case-Control Studies; Cohort Studies; Cysteine; Deficiency Diseases; Dietary Supplements; Dipeptides; Finland; Head and Neck Neoplasms; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Oxidative Stress; Prospective Studies; Randomized Controlled Trials as Topic; Registries; Risk Factors; Smoking; Stomach Neoplasms | 2016 |
Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capillary Permeability; Carcinoma, Squamous Cell; Cysteine; Drug Delivery Systems; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Organoselenium Compounds; Selenocysteine; Xenograft Model Antitumor Assays | 2008 |
Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cell Differentiation; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cysteine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Forkhead Transcription Factors; Head and Neck Neoplasms; Humans; Irinotecan; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Organoselenium Compounds; Selenocysteine; Tirapazamine; Triazines; Xenograft Model Antitumor Assays | 2008 |
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Cysteine; Drug Delivery Systems; Female; Gene Knockdown Techniques; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Irinotecan; Mice; Mice, Nude; Organoselenium Compounds; Reactive Oxygen Species; RNA, Small Interfering; Selenocysteine; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cysteine; ErbB Receptors; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Maleimides; Mice; Mice, Nude; Models, Chemical; Multimodal Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Time Factors; Tissue Distribution; Tomography, X-Ray Computed | 2012 |
Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carcinoma, Squamous Cell; Cysteine; Female; Head and Neck Neoplasms; Humans; Irinotecan; Mice; Mice, Nude; Organoselenium Compounds; Pharmacogenetics; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Selenocysteine; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
Interaction of OGG1 Ser326Cys polymorphism with cigarette smoking in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Carcinoma, Squamous Cell; Cysteine; DNA Glycosylases; Female; Genetic Predisposition to Disease; Genotype; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Polymorphism, Genetic; Serine; Smoking | 2006 |
Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiog
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cysteine; Down-Regulation; Female; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Irinotecan; Mice; Mice, Nude; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Organoselenium Compounds; Selenocysteine; Transplantation, Heterologous | 2006 |
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Asparagine; Aspartic Acid; Carcinoma, Squamous Cell; Cisplatin; Cysteine; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Female; Gene Frequency; Genotype; Glutamine; Head and Neck Neoplasms; Humans; Lysine; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein | 2006 |
Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines.
Topics: Carcinoma, Squamous Cell; Cell Survival; Chromosomes, Human, Pair 11; Cisplatin; Cysteine; Gene Amplification; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Transferase; Head and Neck Neoplasms; Humans; In Vitro Techniques; RNA, Messenger; Tumor Cells, Cultured | 1994 |
The contribution of the RING finger domain of MDM2 to cell cycle progression.
Topics: Amino Acid Sequence; Cell Cycle; Cell Nucleolus; Conserved Sequence; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine; Head and Neck Neoplasms; Humans; Ligases; Molecular Sequence Data; Mutation; Neoplasm Proteins; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Zinc Fingers | 2000 |
Glutathione and cysteine levels in human tumour biopsies.
Topics: Chromatography, High Pressure Liquid; Cysteine; Female; Glutathione; Head and Neck Neoplasms; Humans; Uterine Cervical Neoplasms | 1990 |